• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS BHCG II REAGENT PACK; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS BHCG II REAGENT PACK; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6802220
Device Problem High Readings (2459)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/02/2017
Event Type  malfunction  
Manufacturer Narrative
The investigation has determined that higher than expected vitros bhcg results were obtained from a single patient sample when processed on two vitros 5600 integrated systems.The most likely assignable cause is pre-analytical sample handling leading to possible contamination and/or evaporation of the sample.However, a reagent issue or an instrument issue cannot be completely ruled out, they are not likely to be contributing factors to this event.Additionally, it was unknown if the affected patient sample was centrifuged according to the sample device manufacturer¿s recommendations, therefore, improper pre-analytical sample processing cannot be ruled out as contributing to the event.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.A definitive assignable cause for the event could not be determined.
 
Event Description
A customer obtained higher than expected, vitros bhcg results from a single patient sample when processed on two vitros 5600 integrated systems.Patient sample results of 135.2, 136.2, 145.1, 157.9, 158.6, and 173.3 miu/ml versus expected result <2.39miu/ml.Biased results of the direction and magnitude observed may lead to inappropriate physician action.The higher than expected vitros bhcg results were not reported outside of the laboratory and there was no report of actual patient harm as a result of this event.This report is number two of two mdr¿s for this event.Two 3500a forms are being submitted for this event as two devices were involved.This report corresponds to ortho clinical diagnostics (ortho).(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS BHCG II REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key6438880
MDR Text Key71324863
Report Number3007111389-2017-00038
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeBR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Other
Type of Report Initial
Report Date 03/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/28/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/02/2017
Device Catalogue Number6802220
Device Lot Number1658
Other Device ID Number10758750002320
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Date Manufacturer Received03/03/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/27/2016
Is the Device Single Use? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-